MetaADEDB 2.0 @ LMMD
Venlafaxine Hydrochloride
(QYRYFNHXARDNFZ-UHFFFAOYSA-N)
Structure
SMILES
COc1ccc(cc1)C(C1(O)CCCCC1)CN(C)C.Cl
Molecular Formula:
C17H28ClNO2
Molecular Weight:
313.863
Log P:
3.8376
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
2
TPSA:
32.7
CAS Number(s):
99300-78-4
Synonym(s)
1.
Venlafaxine Hydrochloride
2.
1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol HCl
3.
Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride
4.
Dobupal
5.
Efexor
6.
Effexor
7.
Sila-Venlafaxine
8.
Trevilor
9.
Vandral
10.
Venlafaxine
11.
Wy 45030
12.
Wy-45,030
13.
Wy-45030
14.
Hydrochloride, Venlafaxine
15.
Sila Venlafaxine
16.
Wy 45,030
17.
Wy45,030
18.
Wy45030
External Link(s)
MeSHD000069470
PubChem Compound62923
25137858
BindingDB82072
ChEBI9944
CHEMBLCHEMBL1201066
KEGGdr:D00821
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug withdrawal syndromeFAERS: 1658
Canada Vigilance: 33
Canada Vigilance
US FAERS
2Drug ineffectiveFAERS: 1465
Canada Vigilance: 144
Canada Vigilance
US FAERS
3DizzinessFAERS: 963
Canada Vigilance: 79
7653704CTD
Canada Vigilance
US FAERS
4NauseaFAERS: 905
Canada Vigilance: 83
10732656
15699296
17917556
CTD
Canada Vigilance
US FAERS
5Feeling abnormalFAERS: 813
Canada Vigilance: 22
Canada Vigilance
US FAERS
6HeadacheFAERS: 809
Canada Vigilance: 53
10732656CTD
Canada Vigilance
US FAERS
7AnxietyFAERS: 752
Canada Vigilance: 52
Canada Vigilance
US FAERS
8MalaiseFAERS: 694
Canada Vigilance: 15
Canada Vigilance
US FAERS
9FatigueFAERS: 481
Canada Vigilance: 23
Canada Vigilance
US FAERS
10CryingFAERS: 468
Canada Vigilance: 21
Canada Vigilance
US FAERS
11Drug exposure during pregnancyFAERS: 446US FAERS
12TremorFAERS: 404
Canada Vigilance: 38
8888541
10435776
CTD
Canada Vigilance
US FAERS
13VomitingFAERS: 383
Canada Vigilance: 27
Canada Vigilance
US FAERS
14AstheniaFAERS: 335
Canada Vigilance: 14
15699296CTD
Canada Vigilance
US FAERS
15Drug DependenceFAERS: 326
Canada Vigilance: 8
Canada Vigilance
US FAERS
16PainFAERS: 302
Canada Vigilance: 7
Canada Vigilance
US FAERS
17Suicide attemptFAERS: 280
Canada Vigilance: 13
Canada Vigilance
US FAERS
18AgitationFAERS: 269
Canada Vigilance: 17
Canada Vigilance
US FAERS
19Completed SuicideFAERS: 261
Canada Vigilance: 5
Canada Vigilance
US FAERS
20AngerFAERS: 244
Canada Vigilance: 12
Canada Vigilance
US FAERS
21NervousnessFAERS: 239
Canada Vigilance: 6
Canada Vigilance
US FAERS
22Depressed moodFAERS: 236
Canada Vigilance: 11
Canada Vigilance
US FAERS
23TinnitusFAERS: 236
Canada Vigilance: 19
Canada Vigilance
US FAERS
24SomnolenceFAERS: 227
Canada Vigilance: 16
Canada Vigilance
US FAERS
25OverdoseFAERS: 225
Canada Vigilance: 7
Canada Vigilance
US FAERS
26VertigoFAERS: 220
Canada Vigilance: 11
Canada Vigilance
US FAERS
27PalpitationsFAERS: 215
Canada Vigilance: 14
Canada Vigilance
US FAERS
28ApathyFAERS: 191
Canada Vigilance: 1
Canada Vigilance
US FAERS
29RestlessnessFAERS: 175
Canada Vigilance: 7
Canada Vigilance
US FAERS
30Impaired work abilityFAERS: 158
Canada Vigilance: 6
Canada Vigilance
US FAERS
31MyalgiaFAERS: 156
Canada Vigilance: 3
Canada Vigilance
US FAERS
32Memory impairmentFAERS: 147
Canada Vigilance: 2
Canada Vigilance
US FAERS
33Abdominal discomfortFAERS: 145
Canada Vigilance: 5
Canada Vigilance
US FAERS
34Emotional disorderFAERS: 145
Canada Vigilance: 5
Canada Vigilance
US FAERS
35Activities of daily living impairedFAERS: 143US FAERS
36AmnesiaFAERS: 140
Canada Vigilance: 8
Canada Vigilance
US FAERS
37Product substitution issueFAERS: 136
Canada Vigilance: 66
Canada Vigilance
US FAERS
38Unevaluable eventFAERS: 131
Canada Vigilance: 3
Canada Vigilance
US FAERS
39Drug dose omissionFAERS: 127US FAERS
40nervous system disorderFAERS: 124
Canada Vigilance: 1
Canada Vigilance
US FAERS
41Weight decreasedFAERS: 122
Canada Vigilance: 8
Canada Vigilance
US FAERS
42Mood swingsFAERS: 118
Canada Vigilance: 10
Canada Vigilance
US FAERS
43Psychiatric symptomFAERS: 118US FAERS
44ChillsFAERS: 109
Canada Vigilance: 12
Canada Vigilance
US FAERS
45ConstipationFAERS: 109
Canada Vigilance: 6
15699296
17606668
CTD
Canada Vigilance
US FAERS
46TensionFAERS: 105
Canada Vigilance: 1
Canada Vigilance
US FAERS
47TachycardiaFAERS: 102
Canada Vigilance: 9
11816261CTD
Canada Vigilance
US FAERS
48DisorientationFAERS: 99
Canada Vigilance: 6
Canada Vigilance
US FAERS
49Maternal exposure during pregnancyFAERS: 99
Canada Vigilance: 6
Canada Vigilance
US FAERS
50Feelings of worthlessnessFAERS: 97US FAERS
51PruritusFAERS: 96
Canada Vigilance: 13
Canada Vigilance
US FAERS
52ArthralgiaFAERS: 93
Canada Vigilance: 2
Canada Vigilance
US FAERS
53Night sweatsFAERS: 90
Canada Vigilance: 9
Canada Vigilance
US FAERS
54Feeling jitteryFAERS: 87
Canada Vigilance: 9
Canada Vigilance
US FAERS
55Impaired driving abilityFAERS: 84
Canada Vigilance: 4
Canada Vigilance
US FAERS
56Negative thoughtsFAERS: 81
Canada Vigilance: 1
Canada Vigilance
US FAERS
57Toxicity to various agentsFAERS: 80
Canada Vigilance: 1
Canada Vigilance
US FAERS
58Serotonin SyndromeFAERS: 79
Canada Vigilance: 11

View details

CTD
Canada Vigilance
US FAERS
59Drug effect incompleteFAERS: 78US FAERS
60Prescribed overdoseFAERS: 77
Canada Vigilance: 1
Canada Vigilance
US FAERS
61LethargyFAERS: 76
Canada Vigilance: 6
7653704CTD
Canada Vigilance
US FAERS
62Visual ImpairmentFAERS: 75
Canada Vigilance: 21
Canada Vigilance
US FAERS
63HypersensitivityFAERS: 74
Canada Vigilance: 6
Canada Vigilance
US FAERS
64Product quality issueFAERS: 74
Canada Vigilance: 1
Canada Vigilance
US FAERS
65Chest PainFAERS: 73
Canada Vigilance: 5
Canada Vigilance
US FAERS
66Myocardial InfarctionFAERS: 73US FAERS
67StressFAERS: 70
Canada Vigilance: 1
Canada Vigilance
US FAERS
68MydriasisFAERS: 69
Canada Vigilance: 9
Canada Vigilance
US FAERS
69UrticariaFAERS: 69
Canada Vigilance: 8
Canada Vigilance
US FAERS
70Cerebrovascular accidentFAERS: 68
Canada Vigilance: 1
Canada Vigilance
US FAERS
71Drug ineffective for unapproved indicationFAERS: 65US FAERS
72Therapeutic response unexpectedFAERS: 65
Canada Vigilance: 2
Canada Vigilance
US FAERS
73Blood cholesterol increasedFAERS: 64
Canada Vigilance: 2
Canada Vigilance
US FAERS
74Intentional product misuseFAERS: 64
Canada Vigilance: 5
Canada Vigilance
US FAERS
75Personality ChangeFAERS: 63
Canada Vigilance: 2
Canada Vigilance
US FAERS
76Abdominal PainFAERS: 62
Canada Vigilance: 5
Canada Vigilance
US FAERS
77Nonspecific reactionFAERS: 61
Canada Vigilance: 1
Canada Vigilance
US FAERS
78EpilepsyFAERS: 59
Canada Vigilance: 1
Canada Vigilance
US FAERS
79Mental impairmentFAERS: 58US FAERS
80AlopeciaFAERS: 55
Canada Vigilance: 7
Canada Vigilance
US FAERS
81Visual disturbanceFAERS: 54US FAERS
82Intentional drug misuseFAERS: 53US FAERS
83ParanoiaFAERS: 52
Canada Vigilance: 5
Canada Vigilance
US FAERS
84Maternal exposure timing unspecifiedFAERS: 51US FAERS
85Cardiac ArrestFAERS: 50
Canada Vigilance: 2
Canada Vigilance
US FAERS
86Medication residueFAERS: 50US FAERS
87HypotensionFAERS: 49
Canada Vigilance: 3
Canada Vigilance
US FAERS
88RhabdomyolysisFAERS: 49
Canada Vigilance: 1
Canada Vigilance
US FAERS
89Emotional distressFAERS: 48
Canada Vigilance: 4
Canada Vigilance
US FAERS
90Product use in unapproved indicationFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
91Sexual DysfunctionFAERS: 48
Canada Vigilance: 3
Canada Vigilance
US FAERS
92BedriddenFAERS: 47
Canada Vigilance: 1
Canada Vigilance
US FAERS
93Bipolar DisorderFAERS: 46

View details

CTD
US FAERS
94InfluenzaFAERS: 46US FAERS
95Intentional self-injuryFAERS: 46
Canada Vigilance: 4
Canada Vigilance
US FAERS
96Product use issueFAERS: 45US FAERS
97SyncopeFAERS: 45US FAERS
98Drug screen false positiveFAERS: 43US FAERS
99PhotophobiaFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
100Back PainFAERS: 41
Canada Vigilance: 5
Canada Vigilance
US FAERS
101Cold sweatFAERS: 41
Canada Vigilance: 4
Canada Vigilance
US FAERS
102Euphoric moodFAERS: 40
Canada Vigilance: 4
Canada Vigilance
US FAERS
103Burning sensationFAERS: 39
Canada Vigilance: 1
Canada Vigilance
US FAERS
104DehydrationFAERS: 39
Canada Vigilance: 5
Canada Vigilance
US FAERS
105Erectile dysfunctionFAERS: 39US FAERS
106NasopharyngitisFAERS: 39
Canada Vigilance: 1
Canada Vigilance
US FAERS
107Diabetes MellitusFAERS: 38
Canada Vigilance: 2
Canada Vigilance
US FAERS
108Intentional product use issueFAERS: 38
Canada Vigilance: 2
Canada Vigilance
US FAERS
109Restless Legs SyndromeFAERS: 3818468624CTD
US FAERS
110Drug toxicityFAERS: 37US FAERS
111Head discomfortFAERS: 36US FAERS
112HypersomniaFAERS: 36US FAERS
113Muscle tightnessFAERS: 36
Canada Vigilance: 2
Canada Vigilance
US FAERS
114PregnancyFAERS: 36US FAERS
115HostilityFAERS: 35US FAERS
116Pre-existing condition improvedFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
117CardiomegalyFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
118DiscomfortFAERS: 34US FAERS
119Incorrect dose administeredFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
120BlindnessFAERS: 33US FAERS
121DependenceFAERS: 33US FAERS
122MyoclonusFAERS: 33
Canada Vigilance: 4
8888541CTD
Canada Vigilance
US FAERS
123Urinary RetentionFAERS: 33
Canada Vigilance: 2
9065967
16340381
CTD
Canada Vigilance
US FAERS
124AnorexiaFAERS: 3215699296CTD
US FAERS
125DissociationFAERS: 32US FAERS
126Drug abuseFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
127Drug screen positiveFAERS: 32US FAERS
128Medication ErrorFAERS: 32
Canada Vigilance: 3
Canada Vigilance
US FAERS
129AnorgasmiaFAERS: 31US FAERS
130Blood creatine phosphokinase increasedFAERS: 31
Canada Vigilance: 2
Canada Vigilance
US FAERS
131Disease recurrenceFAERS: 31
Canada Vigilance: 1
Canada Vigilance
US FAERS
132Drug exposure via breast milkFAERS: 31US FAERS
133DysarthriaFAERS: 31
Canada Vigilance: 2
Canada Vigilance
US FAERS
134Eye painFAERS: 31
Canada Vigilance: 3
Canada Vigilance
US FAERS
135Poor quality sleepFAERS: 31
Canada Vigilance: 3
Canada Vigilance
US FAERS
136AkathisiaFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
137DyspepsiaFAERS: 30
Canada Vigilance: 4
Canada Vigilance
US FAERS
138FibromyalgiaFAERS: 30US FAERS
139HyperacusisFAERS: 30
Canada Vigilance: 2
Canada Vigilance
US FAERS
140Musculoskeletal stiffnessFAERS: 30
Canada Vigilance: 2
Canada Vigilance
US FAERS
141Neonatal disorderFAERS: 30
Canada Vigilance: 5
Canada Vigilance
US FAERS
142No adverse eventFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
143Patent ductus arteriosusFAERS: 30US FAERS
144Feeling ColdFAERS: 29US FAERS
145General physical health deteriorationFAERS: 29
Canada Vigilance: 2
Canada Vigilance
US FAERS
146Intentional misuseFAERS: 29US FAERS
147PneumoniaFAERS: 29
Canada Vigilance: 4
12663337CTD
Canada Vigilance
US FAERS
148Depressed Level of ConsciousnessFAERS: 28
Canada Vigilance: 4
Canada Vigilance
US FAERS
149DysgeusiaFAERS: 28
Canada Vigilance: 2
Canada Vigilance
US FAERS
150Flat affectFAERS: 28
Canada Vigilance: 2
Canada Vigilance
US FAERS
151HomicideFAERS: 28US FAERS
152Accidental overdoseFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
153Inappropriate schedule of drug administrationFAERS: 27US FAERS
154BruxismFAERS: 26
Canada Vigilance: 2
Canada Vigilance
US FAERS
155Pulmonary Valve StenosisFAERS: 26US FAERS
156DystoniaFAERS: 25
Canada Vigilance: 1
10405494
20014065
CTD
Canada Vigilance
US FAERS
157HypomaniaFAERS: 25
Canada Vigilance: 4
Canada Vigilance
US FAERS
158PancreatitisFAERS: 25
Canada Vigilance: 6
Canada Vigilance
US FAERS
159Sinus TachycardiaFAERS: 25US FAERS
160AbasiaFAERS: 24US FAERS
161ArthritisFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
162ArthropathyFAERS: 24US FAERS
163Atrial FibrillationFAERS: 24
Canada Vigilance: 1
17116959CTD
Canada Vigilance
US FAERS
164Chest discomfortFAERS: 24
Canada Vigilance: 2
Canada Vigilance
US FAERS
165Drug dispensing errorFAERS: 24US FAERS
166Feeding disorder neonatalFAERS: 24US FAERS
167Physical assaultFAERS: 24US FAERS
168FlatulenceFAERS: 23
Canada Vigilance: 4
Canada Vigilance
US FAERS
169ThrombosisFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
170Hypoplastic Left Heart SyndromeFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
171Mental status changesFAERS: 22
Canada Vigilance: 4
Canada Vigilance
US FAERS
172Obsessive-Compulsive DisorderFAERS: 22
Canada Vigilance: 1
17503984CTD
Canada Vigilance
US FAERS
173Otitis MediaFAERS: 22US FAERS
174Pharmaceutical product complaintFAERS: 22US FAERS
175Wrong technique in drug usage processFAERS: 22US FAERS
176FormicationFAERS: 21US FAERS
177Loss of personal independence in daily activitiesFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
178Panic DisorderFAERS: 21
Canada Vigilance: 1
17589833CTD
Canada Vigilance
US FAERS
179Respiratory distressFAERS: 21
Canada Vigilance: 4
Canada Vigilance
US FAERS
180Urinary tract infectionFAERS: 21US FAERS
181YawningFAERS: 21
Canada Vigilance: 4
Canada Vigilance
US FAERS
182AsphyxiaFAERS: 20US FAERS
183CataractFAERS: 20
Canada Vigilance: 4
Canada Vigilance
US FAERS
184Drug prescribing errorFAERS: 20US FAERS
185HypophagiaFAERS: 20US FAERS
186Middle insomniaFAERS: 20
Canada Vigilance: 2
Canada Vigilance
US FAERS
187Muscle RigidityFAERS: 20
Canada Vigilance: 4
8700462
8888541
CTD
Canada Vigilance
US FAERS
188RetchingFAERS: 20US FAERS
189ScreamingFAERS: 20US FAERS
190Alanine Aminotransferase IncreasedFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
191Blood glucose increasedFAERS: 19US FAERS
192Bone painFAERS: 19US FAERS
193Feeling of body temperature changeFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
194Gamma-Glutamyltransferase IncreasedFAERS: 19US FAERS
195Neck PainFAERS: 19
Canada Vigilance: 3
Canada Vigilance
US FAERS
196PresyncopeFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
197PyelocaliectasisFAERS: 19US FAERS
198SepsisFAERS: 19US FAERS
199Violence-related symptomFAERS: 19US FAERS
200AphasiaFAERS: 18US FAERS
201DeafnessFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
202FlushingFAERS: 18
Canada Vigilance: 7
Canada Vigilance
US FAERS
203FractureFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
204Hypertensive crisisFAERS: 18US FAERS
205InfectionFAERS: 18US FAERS
206Motion SicknessFAERS: 18US FAERS
207ThirstFAERS: 18US FAERS
208BradycardiaFAERS: 17US FAERS
209DementiaFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
210DiplopiaFAERS: 17
Canada Vigilance: 3
Canada Vigilance
US FAERS
211DysphemiaFAERS: 17
Canada Vigilance: 3
Canada Vigilance
US FAERS
212GlaucomaFAERS: 17
Canada Vigilance: 7
Canada Vigilance
US FAERS
213Quality of life decreasedFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
214TalipesFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
215Drug abuserFAERS: 16US FAERS
216Electrocardiogram abnormalFAERS: 16US FAERS
217ErythemaFAERS: 16
Canada Vigilance: 4
Canada Vigilance
US FAERS
218Failure to ThriveFAERS: 16US FAERS
219HyperreflexiaFAERS: 16US FAERS
220IncontinenceFAERS: 16US FAERS
221Musculoskeletal PainFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
222ObesityFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
223Supraventricular tachycardiaFAERS: 16US FAERS
224AsthmaFAERS: 15US FAERS
225Bipolar I disorderFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
226DextrocardiaFAERS: 15US FAERS
227Economic problemFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
228HungerFAERS: 15US FAERS
229Irritable Bowel SyndromeFAERS: 15US FAERS
230Respiratory FailureFAERS: 15US FAERS
231SwellingFAERS: 15
Canada Vigilance: 5
Canada Vigilance
US FAERS
232Urinary IncontinenceFAERS: 15
Canada Vigilance: 2
11147747
16239768
CTD
Canada Vigilance
US FAERS
233AnhedoniaFAERS: 14US FAERS
234Antidepressant drug level increasedFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
235Aspartate Aminotransferase IncreasedFAERS: 14US FAERS
236Back disorderFAERS: 14US FAERS
237HypothyroidismFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
238Post-Traumatic Stress DisorderFAERS: 14US FAERS
239jaundiceFAERS: 14
Canada Vigilance: 2
Canada Vigilance
US FAERS
240Acute kidney injuryFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
241Angina PectorisFAERS: 13US FAERS
242Cerebral disorderFAERS: 13US FAERS
243HypoxiaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
244LacerationFAERS: 13US FAERS
245MalabsorptionFAERS: 13US FAERS
246Skin lesionFAERS: 13US FAERS
247TachyphreniaFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
248Tooth LossFAERS: 13US FAERS
249AtaxiaFAERS: 12US FAERS
250Blood prolactin increasedFAERS: 12
Canada Vigilance: 5
Canada Vigilance
US FAERS
251BradyphreniaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
252CardiotoxicityFAERS: 12US FAERS
253ChromaturiaFAERS: 12US FAERS
254DeliriumFAERS: 12
Canada Vigilance: 3
Canada Vigilance
US FAERS
255Double Outlet Right VentricleFAERS: 12US FAERS
256DysphoniaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
257DysuriaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
258HypokinesiaFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
259Infantile apnoeic attackFAERS: 12US FAERS
260Multiple SclerosisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
261PallorFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
262Rheumatoid ArthritisFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
263Ventricular hypertrophyFAERS: 12US FAERS
264Altered state of consciousnessFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
265AtelectasisFAERS: 11US FAERS
266Cleft PalateFAERS: 11
Canada Vigilance: 2
Canada Vigilance
US FAERS
267Conversion disorderFAERS: 11US FAERS
268CyanosisFAERS: 11US FAERS
269Ear discomfortFAERS: 11US FAERS
270Head titubationFAERS: 11US FAERS
271HyporeflexiaFAERS: 11US FAERS
272IncoherentFAERS: 11US FAERS
273LaryngitisFAERS: 11US FAERS
274Morbid thoughtsFAERS: 11US FAERS
275Muscle SpasticityFAERS: 11US FAERS
276NeuralgiaFAERS: 1112187335CTD
US FAERS
277Pre-EclampsiaFAERS: 11US FAERS
278ShockFAERS: 11US FAERS
279TrismusFAERS: 11US FAERS
280treatment failureFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
281AcneFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
282BronchiolitisFAERS: 10US FAERS
283Depression suicidalFAERS: 10US FAERS
284HemiparesisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
285HyperventilationFAERS: 10US FAERS
286InflammationFAERS: 10US FAERS
287Injury asphyxiationFAERS: 10US FAERS
288Limb injuryFAERS: 10US FAERS
289Obsessive thoughtsFAERS: 10US FAERS
290Peripheral swellingFAERS: 10
Canada Vigilance: 3
Canada Vigilance
US FAERS
291Self MutilationFAERS: 10US FAERS
292Skin lacerationFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
293Stevens-Johnson SyndromeFAERS: 1025811541CTD
US FAERS
294TheftFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
295ThrombocytopeniaFAERS: 10
Canada Vigilance: 2
8888541CTD
Canada Vigilance
US FAERS
296Wrong technique in product usage processFAERS: 10US FAERS
297Adverse eventFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
298Blood creatinine increasedFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
299Blood triglycerides increasedFAERS: 9US FAERS
300Dental cariesFAERS: 9US FAERS
301Drug administration errorFAERS: 9US FAERS
302Ejection Fraction DecreasedFAERS: 9US FAERS
303HepatomegalyFAERS: 9US FAERS
304Joint injuryFAERS: 9US FAERS
305Nerve injuryFAERS: 9US FAERS
306NystagmusFAERS: 9US FAERS
307OsteoporosisFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
308Poor sucking reflexFAERS: 9US FAERS
309Pulmonary EmbolismFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
310Pulmonary FibrosisFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
311Rash erythematousFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
312Tardive DyskinesiaFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
313Therapeutic response changedFAERS: 9
Canada Vigilance: 8
Canada Vigilance
US FAERS
314Therapeutic response unexpected with drug substitutionFAERS: 9US FAERS
315ToothacheFAERS: 9US FAERS
316AngioedemaFAERS: 8
Canada Vigilance: 3
Canada Vigilance
US FAERS
317Angle Closure GlaucomaFAERS: 8US FAERS
318AphagiaFAERS: 8US FAERS
319AsthenopiaFAERS: 8US FAERS
320Blood potassium decreasedFAERS: 8US FAERS
321Drug withdrawal headacheFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
322Gastric BypassFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
323GastritisFAERS: 8US FAERS
324Hepatitis CFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
325HyperthyroidismFAERS: 8US FAERS
326Hypoaesthesia facialFAERS: 8US FAERS
327LymphadenopathyFAERS: 8US FAERS
328Metabolic acidosisFAERS: 8US FAERS
329MicrocephalyFAERS: 8US FAERS
330NephrolithiasisFAERS: 8US FAERS
331Neuroleptic Malignant SyndromeFAERS: 8
Canada Vigilance: 1
10675082
15362259
CTD
Canada Vigilance
US FAERS
332PancytopeniaFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
333PneumonitisFAERS: 8US FAERS
334Product dose omissionFAERS: 8
Canada Vigilance: 4
Canada Vigilance
US FAERS
335Respiratory arrestFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
336Right Ventricular HypertrophyFAERS: 8US FAERS
337Therapeutic product effect incompleteFAERS: 8
Canada Vigilance: 7
Canada Vigilance
US FAERS
338Therapy cessationFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
339White blood cell count decreasedFAERS: 8US FAERS
340Wrong drug administeredFAERS: 8US FAERS
341Acute Coronary SyndromeFAERS: 7US FAERS
342Alcohol abuseFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
343Anaphylactic shockFAERS: 7US FAERS
344Apparent deathFAERS: 7US FAERS
345AppendicitisFAERS: 7US FAERS
346Blood sodium decreasedFAERS: 7US FAERS
347Blood thyroid stimulating hormone increasedFAERS: 7US FAERS
348Blood urine presentFAERS: 7US FAERS
349Cardiac FlutterFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
350Congenital heart valve disorderFAERS: 7US FAERS
351Disease ProgressionFAERS: 7US FAERS
352Disseminated Intravascular CoagulationFAERS: 7US FAERS
353Dissociative disorderFAERS: 7US FAERS
354Disturbance in sexual arousalFAERS: 7US FAERS
355Drug ToleranceFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
356Drug effective for unapproved indicationFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
357EcchymosisFAERS: 7US FAERS
358Emotional povertyFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
359Expired product administeredFAERS: 7US FAERS
360Eye irritationFAERS: 7US FAERS
361Feeding disorder of infancy OR early childhoodFAERS: 7US FAERS
362Gestational DiabetesFAERS: 7US FAERS
363Hallucinations, mixedFAERS: 7US FAERS
364LazinessFAERS: 7US FAERS
365Lipase increasedFAERS: 7US FAERS
366NeutropeniaFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
367OligohydramniosFAERS: 7US FAERS
368Partner stressFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
369Pectus excavatumFAERS: 7US FAERS
370PoisoningFAERS: 7US FAERS
371Poor weight gain neonatalFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
372ProteinuriaFAERS: 7US FAERS
373Pulmonary HypertensionFAERS: 7
Canada Vigilance: 2
Canada Vigilance
US FAERS
374Sinus bradycardiaFAERS: 7US FAERS
375SluggishnessFAERS: 7US FAERS
376SomnambulismFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
377Temperature intoleranceFAERS: 7US FAERS
378Toxic Epidermal NecrolysisFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
379Trisomy 21FAERS: 7US FAERS
380VIIth nerve paralysisFAERS: 7US FAERS
381Vitreous floatersFAERS: 7US FAERS
382Accidental drug intake by childFAERS: 6US FAERS
383AgeusiaFAERS: 6US FAERS
384Ankle FractureFAERS: 6US FAERS
385Atrial tachycardiaFAERS: 6US FAERS
386Atrioventricular BlockFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
387Blood alkaline phosphatase increasedFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
388Circumstance or information capable of leading to medication errorFAERS: 6US FAERS
389Deafness NeurosensoryFAERS: 6US FAERS
390DiverticulumFAERS: 6US FAERS
391Electroencephalogram abnormalFAERS: 6US FAERS
392Exposure during breast feedingFAERS: 6US FAERS
393Food AllergyFAERS: 6US FAERS
394Food cravingFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
395FrustrationFAERS: 6US FAERS
396GastroenteritisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
397HepatotoxicityFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
398ImpatienceFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
399Inappropriate affectFAERS: 6US FAERS
400Intestinal ObstructionFAERS: 6US FAERS
401Labile blood pressureFAERS: 6US FAERS
402Limb discomfortFAERS: 6US FAERS
403Macular degenerationFAERS: 6US FAERS
404MalnutritionFAERS: 6US FAERS
405Medication residue presentFAERS: 6US FAERS
406MetrorrhagiaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
407Musculoskeletal discomfortFAERS: 6US FAERS
408NarcolepsyFAERS: 6US FAERS
409Poor feeding infantFAERS: 6
Canada Vigilance: 4
Canada Vigilance
US FAERS
410Post procedural complicationFAERS: 6US FAERS
411PriapismFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
412Product formulation issueFAERS: 6US FAERS
413Product taste abnormalFAERS: 6US FAERS
414Reversible cerebral vasoconstriction syndromeFAERS: 6US FAERS
415StuporFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
416Tension HeadacheFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
417Transaminases increasedFAERS: 6US FAERS
418Ventricular hypokinesiaFAERS: 6US FAERS
419Ventricular hypoplasiaFAERS: 6US FAERS
420Vulvovaginal drynessFAERS: 6US FAERS
421Abnormal weight gainFAERS: 5US FAERS
422AgranulocytosisFAERS: 5US FAERS
423AlveolitisFAERS: 5US FAERS
424AnosmiaFAERS: 5US FAERS
425AscitesFAERS: 5US FAERS
426Bell's phenomenonFAERS: 5US FAERS
427Blood pressure fluctuationFAERS: 5US FAERS
428Blood testosterone decreasedFAERS: 5US FAERS
429Breast CystFAERS: 5US FAERS
430BronchitisFAERS: 5US FAERS
431Carpal Tunnel SyndromeFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
432Cerebral InfarctionFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
433Cerebral ventricle dilatationFAERS: 5US FAERS
434ChylothoraxFAERS: 5US FAERS
435Congenital scoliosisFAERS: 5US FAERS
436CystitisFAERS: 5US FAERS
437Dacryostenosis acquiredFAERS: 5US FAERS
438Deep Vein ThrombosisFAERS: 5US FAERS
439Dreamy stateFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
440Drug effect delayedFAERS: 5US FAERS
441Dry skinFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
442DysgraphiaFAERS: 5US FAERS
443Electrocardiogram repolarisation abnormalityFAERS: 5US FAERS
444EpistaxisFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
445ExcoriationFAERS: 5US FAERS
446False positive investigation resultFAERS: 5US FAERS
447Frustration tolerance decreasedFAERS: 5US FAERS
448HepatitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
449HerniaFAERS: 5US FAERS
450HyperphagiaFAERS: 5US FAERS
451Impaired gastric emptyingFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
452InfarctionFAERS: 5US FAERS
453Joint swellingFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
454Lip swellingFAERS: 5
Canada Vigilance: 3
Canada Vigilance
US FAERS
455Low density lipoprotein increasedFAERS: 5US FAERS
456MenopauseFAERS: 5US FAERS
457MicrogeniaFAERS: 5US FAERS
458Mitral Valve StenosisFAERS: 5US FAERS
459MurderFAERS: 5US FAERS
460NegativismFAERS: 5US FAERS
461Neonatal respiratory depressionFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
462Ocular HypertensionFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
463Oropharyngeal painFAERS: 5US FAERS
464Oropharyngeal swellingFAERS: 5US FAERS
465Poor peripheral circulationFAERS: 5US FAERS
466Poor quality drug administeredFAERS: 5US FAERS
467Product physical issueFAERS: 5US FAERS
468Psychomotor skills impairedFAERS: 5US FAERS
469Purulent dischargeFAERS: 5US FAERS
470Sinus ArrhythmiaFAERS: 5US FAERS
471SinusitisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
472Stereotypic Movement DisorderFAERS: 59798262CTD
US FAERS
473StillbirthFAERS: 5US FAERS
474Sudden infant death syndromeFAERS: 5US FAERS
475Suspected counterfeit productFAERS: 5US FAERS
476Therapy non-responderFAERS: 5US FAERS
477Throat irritationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
478Tongue bitingFAERS: 5US FAERS
479UlcerFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
480Unresponsive to stimuliFAERS: 5US FAERS
481Urinary hesitationFAERS: 5US FAERS
482Ventricular FibrillationFAERS: 5US FAERS
483Victim of homicideFAERS: 5US FAERS
484Abnormal sleep-related eventFAERS: 4US FAERS
485Accidental exposureFAERS: 4US FAERS
486Activation syndromeFAERS: 4US FAERS
487Acute myocardial infarctionFAERS: 4US FAERS
488Alcohol interactionFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
489Alcohol poisoningFAERS: 4US FAERS
490Altered visual depth perceptionFAERS: 4US FAERS
491AneurysmFAERS: 4US FAERS
492ArteriosclerosisFAERS: 4US FAERS
493Bicuspid aortic valveFAERS: 4US FAERS
494Bipolar II disorderFAERS: 4US FAERS
495Bladder spasmFAERS: 4US FAERS
496Blood urea increasedFAERS: 4US FAERS
497Blunted affectFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
498Bulimia NervosaFAERS: 4US FAERS
499Cardiac infectionFAERS: 4US FAERS
500Cerebral atrophyFAERS: 4US FAERS
501ChokingFAERS: 4US FAERS
502CholelithiasisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
503CholestasisFAERS: 4
Canada Vigilance: 1
10691596CTD
Canada Vigilance
US FAERS
504ClumsinessFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
505Coma scale abnormalFAERS: 4US FAERS
506Complications of maternal exposure to therapeutic drugsFAERS: 4US FAERS
507Compulsive sexual behaviourFAERS: 4US FAERS
508Congenital choroid plexus cystFAERS: 4US FAERS
509Deja VuFAERS: 4US FAERS
510Delayed deliveryFAERS: 4US FAERS
511Delusional disorder, unspecified typeFAERS: 4US FAERS
512Diabetes mellitus inadequate controlFAERS: 4US FAERS
513DiverticulitisFAERS: 4US FAERS
514EclampsiaFAERS: 4US FAERS
515EczemaFAERS: 4US FAERS
516EructationFAERS: 4US FAERS
517Food PoisoningFAERS: 4US FAERS
518Food aversionFAERS: 4US FAERS
519Gait inabilityFAERS: 4US FAERS
520Gastrointestinal motility disorderFAERS: 4US FAERS
521GastroschisisFAERS: 4US FAERS
522HemiplegiaFAERS: 4US FAERS
523Hypertensive emergencyFAERS: 4US FAERS
524Inappropriate schedule of product administrationFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
525Incorrect drug dosage form administeredFAERS: 4US FAERS
526Initial insomniaFAERS: 4US FAERS
527LeukocytosisFAERS: 4US FAERS
528Long QT SyndromeFAERS: 4US FAERS
529Lung consolidationFAERS: 4US FAERS
530MYELODYSPLASTIC SYNDROMEFAERS: 4US FAERS
531Multiple drug overdose intentionalFAERS: 4US FAERS
532Ocular discomfortFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
533OculogyrationFAERS: 4US FAERS
534Optic NeuritisFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
535Osteogenesis ImperfectaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
536ParapsoriasisFAERS: 4US FAERS
537Performance status decreasedFAERS: 4US FAERS
538PiloerectionFAERS: 4US FAERS
539PolydipsiaFAERS: 4US FAERS
540PolyneuropathyFAERS: 4US FAERS
541Product comminglingFAERS: 4US FAERS
542Pulmonary EosinophiliaFAERS: 4US FAERS
543Pulmonary congestionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
544Pyloric StenosisFAERS: 4US FAERS
545Reaction to drug excipientsFAERS: 4US FAERS
546Renal painFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
547RosaceaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
548Sexual abuseFAERS: 4US FAERS
549SnoringFAERS: 4US FAERS
550SoporFAERS: 4US FAERS
551Status EpilepticusFAERS: 4US FAERS
552Stool analysis abnormalFAERS: 4US FAERS
553Temperature regulation disorderFAERS: 4US FAERS
554Therapy changeFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
555Tibial torsionFAERS: 4US FAERS
556Tobacco userFAERS: 4US FAERS
557Tooth ErosionFAERS: 4US FAERS
558Upper respiratory tract congestionFAERS: 4US FAERS
559Waxy flexibilityFAERS: 4US FAERS
560WheezingFAERS: 4US FAERS
561AbscessFAERS: 3US FAERS
562Acute respiratory failureFAERS: 3US FAERS
563Alcohol IntoleranceFAERS: 3US FAERS
564Allergic reaction to excipientFAERS: 3US FAERS
565Anticholinergic SyndromeFAERS: 3US FAERS
566Aortic AneurysmFAERS: 3US FAERS
567Atrial FlutterFAERS: 3US FAERS
568Atrioventricular Septal DefectFAERS: 3US FAERS
569Benign Prostatic HyperplasiaFAERS: 3US FAERS
570Blood alcohol increasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
571Blood catecholamines increasedFAERS: 3US FAERS
572Blood count abnormalFAERS: 3US FAERS
573Blood glucose abnormalFAERS: 3US FAERS
574Blood glucose fluctuationFAERS: 3US FAERS
575Blood lactate dehydrogenase increasedFAERS: 3US FAERS
576Body temperature fluctuationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
577Bowel movement irregularityFAERS: 3US FAERS
578Breech PresentationFAERS: 3US FAERS
579Brief psychotic disorder with marked stressorsFAERS: 3US FAERS
580Carbon Monoxide PoisoningFAERS: 3US FAERS
581CellulitisFAERS: 3US FAERS
582Central nervous system lesionFAERS: 3US FAERS
583Cerebral PalsyFAERS: 3US FAERS
584Cerebral ThrombosisFAERS: 3US FAERS
585Cerebral atrophy congenitalFAERS: 3US FAERS
586ClonusFAERS: 3US FAERS
587Cluster HeadacheFAERS: 3US FAERS
588ColitisFAERS: 3US FAERS
589Complication of deliveryFAERS: 3US FAERS
590Dark circles under eyesFAERS: 3US FAERS
591Delusional disorder, persecutory typeFAERS: 3US FAERS
592DemyelinationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
593DiaphragmalgiaFAERS: 3US FAERS
594DisabilityFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
595Drug administered to patient of inappropriate ageFAERS: 3US FAERS
596Drug level decreasedFAERS: 3US FAERS
597Drug withdrawal convulsionsFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
598Drug withdrawal maintenance therapyFAERS: 3US FAERS
599Educational problemFAERS: 3US FAERS
600Electrocardiogram QT interval abnormalFAERS: 3US FAERS
601EnteritisFAERS: 3US FAERS
602Epilepsy congenitalFAERS: 3US FAERS
603Exposure via breast milkFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
604GamblingFAERS: 3US FAERS
605Gastrointestinal PainFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
606Gastrointestinal inflammationFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
607Glasgow coma scale abnormalFAERS: 3US FAERS
608Growth retardationFAERS: 3US FAERS
609Histrionic Personality DisorderFAERS: 3US FAERS
610HypervigilanceFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
611HypospadiasFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
612HypoventilationFAERS: 3US FAERS
613Incorrect drug administration rateFAERS: 3US FAERS
614Incorrect storage of drugFAERS: 3US FAERS
615Intracranial AneurysmFAERS: 3US FAERS
616Joint stiffnessFAERS: 3US FAERS
617Lactation DisorderFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
618Libido disorderFAERS: 3US FAERS
619Lichen PlanusFAERS: 3US FAERS
620Lymphocyte count decreasedFAERS: 3US FAERS
621Male Orgasmic DisorderFAERS: 3US FAERS
622Malignant HypertensionFAERS: 3US FAERS
623Maternal exposure during breast feedingFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
624MeningomyeloceleFAERS: 3US FAERS
625Mouth swellingFAERS: 3US FAERS
626Muscle FatigueFAERS: 3US FAERS
627Myoclonic EpilepsyFAERS: 3US FAERS
628MyopiaFAERS: 3US FAERS
629MyositisFAERS: 3US FAERS
630Neonatal infectionFAERS: 3US FAERS
631Neonatal respiratory failureFAERS: 3US FAERS
632Oculogyric crisisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
633OnychoclasisFAERS: 3US FAERS
634Orgasmic sensation decreasedFAERS: 3US FAERS
635Pain of skinFAERS: 3US FAERS
636Pancreatic carcinomaFAERS: 3US FAERS
637Pancreatic enzymes increasedFAERS: 3US FAERS
638Parent-child problemFAERS: 3US FAERS
639Pathological fractureFAERS: 3US FAERS
640PetechiaeFAERS: 3US FAERS
641Pneumocystis test positiveFAERS: 3US FAERS
642Poor quality product administeredFAERS: 3US FAERS
643Premature MenopauseFAERS: 3US FAERS
644Pressure of speechFAERS: 3US FAERS
645Product packaging issueFAERS: 3US FAERS
646Product residue presentFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
647Product size issueFAERS: 3US FAERS
648Product solubility abnormalFAERS: 3US FAERS
649Psychiatric decompensationFAERS: 3US FAERS
650Pulmonary vascular disorderFAERS: 3US FAERS
651PurpuraFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
652Reaction to excipientFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
653Rebound effectFAERS: 3US FAERS
654Respiratory DepressionFAERS: 3US FAERS
655Retinal DetachmentFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
656Rotator cuff syndromeFAERS: 3US FAERS
657SarcoidosisFAERS: 3US FAERS
658SchizophreniaFAERS: 312380707CTD
US FAERS
659ScotomaFAERS: 3US FAERS
660Serum serotonin decreasedFAERS: 3US FAERS
661Sjogren's SyndromeFAERS: 3US FAERS
662Skin UlcerFAERS: 3US FAERS
663Sleep ParalysisFAERS: 3US FAERS
664Spinal column stenosisFAERS: 3US FAERS
665StomatitisFAERS: 3US FAERS
666Sudden deathFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
667TetanyFAERS: 3US FAERS
668Thermal burnFAERS: 3US FAERS
669Toxicologic test abnormalFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
670Traumatic Brain InjuryFAERS: 3US FAERS
671Umbilical herniaFAERS: 3US FAERS
672UnderweightFAERS: 3US FAERS
673Vaginal DischargeFAERS: 3US FAERS
674Ventricular arrhythmiaFAERS: 3US FAERS
675Victim of spousal abuseFAERS: 3US FAERS
676Weight decrease neonatalFAERS: 3US FAERS
677effusionFAERS: 3US FAERS
678furuncleFAERS: 3US FAERS
679Accidental exposure to productFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
680Accidental exposure to product by childFAERS: 2US FAERS
681AcidosisFAERS: 2US FAERS
682Acute psychosisFAERS: 2US FAERS
683AdactylyFAERS: 2US FAERS
684Adenomatous Polyposis ColiFAERS: 2US FAERS
685Agitated depressionFAERS: 2US FAERS
686AgoraphobiaFAERS: 2US FAERS
687Alcohol Use DisorderFAERS: 2US FAERS
688Alpha 1 foetoprotein decreasedFAERS: 2US FAERS
689Amaurosis FugaxFAERS: 2US FAERS
690Amphetamines positiveFAERS: 2US FAERS
691Anal sphincter atonyFAERS: 2US FAERS
692AnhidrosisFAERS: 2US FAERS
693Antiphospholipid antibodies positiveFAERS: 2US FAERS
694Apallic syndromeFAERS: 2US FAERS
695AphoniaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
696AuraFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
697Autoimmune hepatitisFAERS: 2US FAERS
698Autonomic nervous system imbalanceFAERS: 2US FAERS
699AutoscopyFAERS: 2US FAERS
700Band neutrophil count increasedFAERS: 2US FAERS
701Bladder painFAERS: 2US FAERS
702Bladder prolapseFAERS: 2US FAERS
703Bladder trabeculationFAERS: 2US FAERS
704Blood amylase increasedFAERS: 2US FAERS
705Blood cholesterol abnormalFAERS: 2US FAERS
706Blood glucose decreasedFAERS: 2US FAERS
707Blood pH decreasedFAERS: 2US FAERS
708Blood potassium abnormalFAERS: 2US FAERS
709Blood potassium increasedFAERS: 2US FAERS
710Brain natriuretic peptide increasedFAERS: 2US FAERS
711BronchiectasisFAERS: 2
Canada Vigilance: 4
Canada Vigilance
US FAERS
712CalcinosisFAERS: 2US FAERS
713CandidiasisFAERS: 2US FAERS
714CataplexyFAERS: 215910521CTD
US FAERS
715CatatoniaFAERS: 2US FAERS
716Catheter related complicationFAERS: 2US FAERS
717ChromatopsiaFAERS: 2US FAERS
718Clostridium difficile infectionFAERS: 2US FAERS
719Cogwheel RigidityFAERS: 2US FAERS
720ColectomyFAERS: 2US FAERS
721Compulsive shoppingFAERS: 2US FAERS
722Concomitant disease aggravatedFAERS: 2US FAERS
723Congenital aqueductal stenosisFAERS: 2US FAERS
724Congenital pulmonary hypertensionFAERS: 2US FAERS
725CraniosynostosisFAERS: 2US FAERS
726Creutzfeldt-Jakob diseaseFAERS: 2US FAERS
727Death of relativeFAERS: 2US FAERS
728Delusional disorder, somatic typeFAERS: 2US FAERS
729DermatitisFAERS: 2US FAERS
730DermatomyositisFAERS: 2US FAERS
731Device FailureFAERS: 2US FAERS
732Diastolic hypertensionFAERS: 2US FAERS
733Drug dispensed to wrong patientFAERS: 2US FAERS
734Drug effect variableFAERS: 2US FAERS
735Drug exposure before pregnancyFAERS: 2US FAERS
736Drug level above therapeuticFAERS: 2US FAERS
737Drug level increasedFAERS: 2US FAERS
738Drug resistanceFAERS: 2US FAERS
739DuodenitisFAERS: 2US FAERS
740DyslexiaFAERS: 2US FAERS
741DyspareuniaFAERS: 2US FAERS
742DysphasiaFAERS: 2US FAERS
743Ear tube insertionFAERS: 2US FAERS
744Electrocardiogram changeFAERS: 2US FAERS
745Elevated moodFAERS: 2US FAERS
746EncephaloceleFAERS: 2US FAERS
747EnuresisFAERS: 2US FAERS
748EosinophiliaFAERS: 2US FAERS
749Eosinophilic PneumoniaFAERS: 2US FAERS
750Epigastric discomfortFAERS: 2US FAERS
751Erythema MultiformeFAERS: 2US FAERS
752ErythroblastosisFAERS: 2US FAERS
753Essential TremorFAERS: 2US FAERS
754ExophthalmosFAERS: 2US FAERS
755Expired drug administeredFAERS: 2US FAERS
756Eyelid margin crustingFAERS: 2US FAERS
757Eyelid rashFAERS: 2US FAERS
758Finger hypoplasiaFAERS: 2US FAERS
759Foaming at mouthFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
760Gait deviationFAERS: 2US FAERS
761Gastrointestinal carcinomaFAERS: 2US FAERS
762GlossitisFAERS: 2US FAERS
763Glossopharyngeal nerve paralysisFAERS: 2US FAERS
764Glycogen storage disease type IIFAERS: 2US FAERS
765Guillain-Barre SyndromeFAERS: 2US FAERS
766Haptoglobin DecreasedFAERS: 2US FAERS
767Heat StrokeFAERS: 2US FAERS
768Hepatic infiltration eosinophilicFAERS: 2US FAERS
769Hepatitis AFAERS: 2US FAERS
770Hepatitis BFAERS: 2US FAERS
771Hip DysplasiaFAERS: 2US FAERS
772Histamine level increasedFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
773Hormone level abnormalFAERS: 2US FAERS
774HydrocephalusFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
775HydronephrosisFAERS: 2US FAERS
776HyperchlorhydriaFAERS: 2US FAERS
777Hyperemesis GravidarumFAERS: 2US FAERS
778Hyperkeratosis palmaris and plantarisFAERS: 2US FAERS
779HyperpyrexiaFAERS: 2US FAERS
780Hypertensive EncephalopathyFAERS: 2US FAERS
781HysterectomyFAERS: 2US FAERS
782Iatrogenic injuryFAERS: 2US FAERS
783IleusFAERS: 2US FAERS
784ImmobileFAERS: 2US FAERS
785Impaired quality of lifeFAERS: 2US FAERS
786Impaired reasoningFAERS: 2US FAERS
787Impaired self-careFAERS: 2US FAERS
788Increased tendency to bruiseFAERS: 2US FAERS
789Increased ventricular afterloadFAERS: 2US FAERS
790Infantile vomitingFAERS: 2
Canada Vigilance: 5
Canada Vigilance
US FAERS
791InfertilityFAERS: 2US FAERS
792Insurance issueFAERS: 2US FAERS
793Intellectual DisabilityFAERS: 2US FAERS
794Intercepted drug dispensing errorFAERS: 2US FAERS
795Lacrimation decreasedFAERS: 2US FAERS
796LaryngospasmFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
797LeukopeniaFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
798Ligament ruptureFAERS: 2US FAERS
799Lower Urinary Tract SymptomsFAERS: 2US FAERS
800Lymphocyte count increasedFAERS: 2US FAERS
801Maternal exposure before pregnancyFAERS: 2US FAERS
802MegacolonFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
803MeningitisFAERS: 2US FAERS
804MenorrhagiaFAERS: 2US FAERS
805MicroglossiaFAERS: 2US FAERS
806Monocyte count decreasedFAERS: 2US FAERS
807Multi-organ disorderFAERS: 2US FAERS
808Muscle CrampFAERS: 2US FAERS
809Muscle necrosisFAERS: 2US FAERS
810Musculoskeletal chest painFAERS: 2US FAERS
811MutismFAERS: 2US FAERS
812NecrosisFAERS: 2US FAERS
813Neonatal aspirationFAERS: 2US FAERS
814Neonatal hypotensionFAERS: 2US FAERS
815Neonatal respiratory arrestFAERS: 2US FAERS
816NeurodermatitisFAERS: 2US FAERS
817Neutrophil percentage increasedFAERS: 2US FAERS
818Nicotine DependenceFAERS: 2US FAERS
819NocturiaFAERS: 2US FAERS
820Norepinephrine increasedFAERS: 2US FAERS
821Normetanephrine urine increasedFAERS: 2US FAERS
822Nuchal RigidityFAERS: 2US FAERS
823Obesity surgeryFAERS: 2US FAERS
824Oral candidiasisFAERS: 2US FAERS
825OverweightFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
826Penile size reducedFAERS: 2US FAERS
827Pericardial effusionFAERS: 2US FAERS
828Peripheral embolismFAERS: 2US FAERS
829Peripheral paralysisFAERS: 2US FAERS
830PneumothoraxFAERS: 2US FAERS
831PolydactylyFAERS: 2US FAERS
832PosturingFAERS: 2US FAERS
833Product contamination physicalFAERS: 2US FAERS
834Product lot number issueFAERS: 2US FAERS
835Product measured potency issueFAERS: 2US FAERS
836Product packaging quantity issueFAERS: 2US FAERS
837Product storage errorFAERS: 2US FAERS
838Progressive multiple sclerosisFAERS: 2US FAERS
839ProlactinomaFAERS: 2US FAERS
840Protein urine presentFAERS: 2US FAERS
841PsoriasisFAERS: 2US FAERS
842Renal ColicFAERS: 2US FAERS
843Respiratory tract inflammationFAERS: 2US FAERS
844RetinitisFAERS: 2US FAERS
845Retroperitoneal fibrosisFAERS: 2US FAERS
846SciaticaFAERS: 2US FAERS
847SclerodactyliaFAERS: 2US FAERS
848SclerodermaFAERS: 2US FAERS
849Selective eating disorderFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
850Semen volume decreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
851Shock symptomFAERS: 2US FAERS
852Skeletal injuryFAERS: 2US FAERS
853Sleep TalkingFAERS: 2US FAERS
854SneezingFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
855SplenomegalyFAERS: 2US FAERS
856Squamous cell carcinomaFAERS: 2US FAERS
857StrabismusFAERS: 2US FAERS
858Sudden Cardiac DeathFAERS: 2US FAERS
859Systemic lupus erythematosus rashFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
860TachyarrhythmiaFAERS: 2US FAERS
861Tooth ExtractionFAERS: 2US FAERS
862Transmission of drug via semenFAERS: 2US FAERS
863Troponin increasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
864Tympanic Membrane PerforationFAERS: 2US FAERS
865Urine ketone body presentFAERS: 2US FAERS
866Urine output increasedFAERS: 2US FAERS
867Vagus nerve paralysisFAERS: 2US FAERS
868VasculitisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
869Ventricle ruptureFAERS: 2US FAERS
870Vestibular NeuronitisFAERS: 2US FAERS
871Victim of child abuseFAERS: 2US FAERS
872Vocal Cord ParalysisFAERS: 2US FAERS
873Wolff-Parkinson-White SyndromeFAERS: 2US FAERS
874Wrong product administeredFAERS: 2US FAERS
875muscle injuryFAERS: 2US FAERS
876prostatitisFAERS: 2US FAERS
8775-hydroxyindolacetic acid in urine increasedFAERS: 1US FAERS
878ABO incompatibilityFAERS: 1US FAERS
879Abdominal AbscessFAERS: 1US FAERS
880Abdominal rigidityFAERS: 1US FAERS
881Abdominal symptomFAERS: 1US FAERS
882Abdominal tendernessFAERS: 1US FAERS
883Abnormal clotting factorFAERS: 1US FAERS
884AchlorhydriaFAERS: 1US FAERS
885Acute Lung InjuryFAERS: 1US FAERS
886AdrenalitisFAERS: 1US FAERS
887Alcohol problemFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
888Aldolase increasedFAERS: 1US FAERS
889Alpha 2 globulin increasedFAERS: 1US FAERS
890Ammonia increasedFAERS: 1US FAERS
891Amniotic fluid volume decreasedFAERS: 1US FAERS
892Amyotrophic Lateral SclerosisFAERS: 1US FAERS
893AnencephalyFAERS: 1US FAERS
894Angiogram abnormalFAERS: 1US FAERS
895Animal biteFAERS: 1US FAERS
896Anorectal agenesisFAERS: 1US FAERS
897Anti-cyclic citrullinated peptide antibody positiveFAERS: 1US FAERS
898Antidepressant drug clearance increasedFAERS: 1US FAERS
899AnuriaFAERS: 1US FAERS
900Apgar score abnormalFAERS: 1US FAERS
901Arteriovenous fistulaFAERS: 1US FAERS
902Arthropod stingFAERS: 1US FAERS
903Artificial rupture of membranesFAERS: 1US FAERS
904Atrial conduction time prolongationFAERS: 1US FAERS
905Auricular swellingFAERS: 1US FAERS
906AutomatismFAERS: 1US FAERS
907Autonomic neuropathyFAERS: 1US FAERS
908Autosomal chromosome anomalyFAERS: 1US FAERS
909Bacteria stool identifiedFAERS: 1US FAERS
910BankruptcyFAERS: 1US FAERS
911Basal cell carcinomaFAERS: 1US FAERS
912BelligerenceFAERS: 1US FAERS
913Biliary ColicFAERS: 1US FAERS
914BilirubinuriaFAERS: 1US FAERS
915Binge DrinkingFAERS: 1US FAERS
916Birth markFAERS: 1US FAERS
917Bladder NeoplasmFAERS: 1US FAERS
918Bladder cancer recurrentFAERS: 1US FAERS
919BlepharospasmFAERS: 1US FAERS
920Blighted ovumFAERS: 1US FAERS
921Blood albumin decreasedFAERS: 1US FAERS
922Blood alcohol abnormalFAERS: 1US FAERS
923Blood blisterFAERS: 1US FAERS
924Blood chromogranin A increasedFAERS: 1US FAERS
925Blood cortisol increasedFAERS: 1US FAERS
926Blood creatine increasedFAERS: 1US FAERS
927Blood creatine phosphokinase MB abnormalFAERS: 1US FAERS
928Blood creatinine decreasedFAERS: 1US FAERS
929Blood electrolytes abnormalFAERS: 1US FAERS
930Blood electrolytes decreasedFAERS: 1US FAERS
931Blood ethanol increasedFAERS: 1US FAERS
932Blood folate decreasedFAERS: 1US FAERS
933Blood follicle stimulating hormone increasedFAERS: 1US FAERS
934Blood insulin decreasedFAERS: 1US FAERS
935Blood phosphorus increasedFAERS: 1US FAERS
936Blood pressure inadequately controlledFAERS: 1US FAERS
937Blood pressure orthostatic abnormalFAERS: 1US FAERS
938Blood smear test abnormalFAERS: 1US FAERS
939Blood sodium increasedFAERS: 1US FAERS
940Blood triglycerides decreasedFAERS: 1US FAERS
941Bone density decreasedFAERS: 1US FAERS
942BradykinesiaFAERS: 1US FAERS
943Brain HypoxiaFAERS: 1US FAERS
944Breast tendernessFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
945Breath alcohol test positiveFAERS: 1US FAERS
946Bronchial ObstructionFAERS: 1US FAERS
947BursitisFAERS: 1US FAERS
948Cancer PainFAERS: 1US FAERS
949Carbon dioxide increasedFAERS: 1US FAERS
950Cardiac discomfortFAERS: 1US FAERS
951Cardiac dysfunctionFAERS: 1US FAERS
952Cardiac enzymes increasedFAERS: 1US FAERS
953Cardiac septal hypertrophyFAERS: 1US FAERS
954Cardiac valve replacement complicationFAERS: 1US FAERS
955Cardiac ventriculogram right abnormalFAERS: 1US FAERS
956Carotid artery aneurysmFAERS: 1US FAERS
957Cauda Equina SyndromeFAERS: 1US FAERS
958Central nervous system function test abnormalFAERS: 1US FAERS
959Central nervous system massFAERS: 1US FAERS
960Cerebral hypoperfusionFAERS: 1US FAERS
961Cerebrospinal fistulaFAERS: 1US FAERS
962Cervix carcinomaFAERS: 1US FAERS
963Childhood disintegrative disorderFAERS: 1US FAERS
964ChloropsiaFAERS: 1US FAERS
965Cholestatic liver injuryFAERS: 1US FAERS
966ChoreaFAERS: 1US FAERS
967ChoreoathetosisFAERS: 1US FAERS
968Chronic Fatigue SyndromeFAERS: 1US FAERS
969Chronic sinusitisFAERS: 1US FAERS
970Clot retractionFAERS: 1US FAERS
971Coagulation factor V level decreasedFAERS: 1US FAERS
972Coagulation factor V level increasedFAERS: 1US FAERS
973Colon cancer recurrentFAERS: 1US FAERS
974Colonoscopy abnormalFAERS: 1US FAERS
975Combined immunodeficiencyFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
976Compression fractureFAERS: 1US FAERS
977Concomitant disease progressionFAERS: 1US FAERS
978Congenital HypothyroidismFAERS: 1US FAERS
979Congenital brain damageFAERS: 1US FAERS
980Congenital cerebellar agenesisFAERS: 1US FAERS
981Congenital cystic kidney diseaseFAERS: 1US FAERS
982Congenital cystic lungFAERS: 1US FAERS
983Congenital diaphragmatic herniaFAERS: 1US FAERS
984Congenital neurological disorderFAERS: 1US FAERS
985Congenital renal cystFAERS: 1US FAERS
986Contact lens intoleranceFAERS: 1US FAERS
987Corneal erosionFAERS: 1US FAERS
988Coronary Artery DiseaseFAERS: 1US FAERS
989Coronary artery embolismFAERS: 1US FAERS
990Corticobasal degenerationFAERS: 1US FAERS
991Counterfeit drug administeredFAERS: 1US FAERS
992Creatinine urine decreasedFAERS: 1US FAERS
993CyanopsiaFAERS: 1US FAERS
994Cyclosporidium infectionFAERS: 1US FAERS
995CystinosisFAERS: 1US FAERS
996CystFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
997Cytolytic hepatitisFAERS: 1US FAERS
998Dandy-Walker SyndromeFAERS: 1US FAERS
999Deep Brain StimulationFAERS: 1US FAERS
1000DeformityFAERS: 1US FAERS
1001Delusional perceptionFAERS: 1US FAERS
1002Dependent ruborFAERS: 1US FAERS
1003Dermatitis HerpetiformisFAERS: 1US FAERS
1004Device related infectionFAERS: 1US FAERS
1005Diabetes InsipidusFAERS: 1US FAERS
1006Dissociative Identity DisorderFAERS: 1US FAERS
1007Dopamine dysregulation syndromeFAERS: 1US FAERS
1008DroolingFAERS: 1US FAERS
1009Drug clearance decreasedFAERS: 1US FAERS
1010Dural tearFAERS: 1US FAERS
1011DyscalculiaFAERS: 1US FAERS
1012DyslaliaFAERS: 1US FAERS
1013DysmorphismFAERS: 1US FAERS
1014Ectopic PregnancyFAERS: 1US FAERS
1015Electrocardiogram PQ interval prolongedFAERS: 1US FAERS
1016Electrocardiogram ST segment abnormalFAERS: 1US FAERS
1017Electrocardiogram ST-T segment abnormalFAERS: 1US FAERS
1018Electrolyte depletionFAERS: 1US FAERS
1019Electrolyte imbalanceFAERS: 1US FAERS
1020EmbolismFAERS: 1US FAERS
1021Endodontic procedureFAERS: 1US FAERS
1022Endolymphatic HydropsFAERS: 1US FAERS
1023Endometrial HyperplasiaFAERS: 1US FAERS
1024EndometriosisFAERS: 1US FAERS
1025Endoscopy upper gastrointestinal tract abnormalFAERS: 1US FAERS
1026Enlarged uvulaFAERS: 1US FAERS
1027Enzyme abnormalityFAERS: 1US FAERS
1028EpididymitisFAERS: 1US FAERS
1029Exaggerated startle responseFAERS: 1US FAERS
1030Excessive masturbationFAERS: 1US FAERS
1031ExcitabilityFAERS: 1US FAERS
1032Exposure via inhalationFAERS: 1US FAERS
1033ExsanguinationFAERS: 1US FAERS
1034Eye InfectionFAERS: 1US FAERS
1035Eye RednessFAERS: 1US FAERS
1036Eye inflammationFAERS: 1US FAERS
1037Eyelid Function DisorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1038Eyelids pruritusFAERS: 1US FAERS
1039Facial PainFAERS: 1US FAERS
1040Factor VII DeficiencyFAERS: 1US FAERS
1041Failure of child resistant mechanism for pharmaceutical productFAERS: 1US FAERS
1042Feeding problem in childFAERS: 1US FAERS
1043Feeding tube complicationFAERS: 1US FAERS
1044Female sexual arousal disorderFAERS: 1US FAERS
1045Flank PainFAERS: 1US FAERS
1046Focal Nodular HyperplasiaFAERS: 1US FAERS
1047Focal dyscognitive seizuresFAERS: 1US FAERS
1048Foreign body aspirationFAERS: 1US FAERS
1049Frontotemporal dementiaFAERS: 1US FAERS
1050GammopathyFAERS: 1US FAERS
1051GastrectomyFAERS: 1US FAERS
1052Gastric pH decreasedFAERS: 1US FAERS
1053Gastrocardiac syndromeFAERS: 1US FAERS
1054Gastrointestinal infectionFAERS: 1US FAERS
1055Gastrointestinal mucosal necrosisFAERS: 1US FAERS
1056Gastrointestinal ulcerFAERS: 1US FAERS
1057Gaze palsyFAERS: 1US FAERS
1058Gene mutation identification test positiveFAERS: 1US FAERS
1059General physical condition abnormalFAERS: 1US FAERS
1060General physical condition decreasedFAERS: 1US FAERS
1061Genital abscessFAERS: 1US FAERS
1062Genital painFAERS: 1US FAERS
1063Gingival RecessionFAERS: 1US FAERS
1064Global AmnesiaFAERS: 1US FAERS
1065GlycosuriaFAERS: 1US FAERS
1066Granulocyte count increasedFAERS: 1US FAERS
1067Granulocytes abnormalFAERS: 1US FAERS
1068Grip strength decreasedFAERS: 1US FAERS
1069HalitosisFAERS: 1US FAERS
1070Head BangingFAERS: 1US FAERS
1071Head deformityFAERS: 1US FAERS
1072Hepatic EncephalopathyFAERS: 1US FAERS
1073Hepatic necrosisFAERS: 1US FAERS
1074Hepatitis B surface antigen positiveFAERS: 1US FAERS
1075Herbal interactionFAERS: 1US FAERS
1076High density lipoprotein increasedFAERS: 1US FAERS
1077Hip surgeryFAERS: 1US FAERS
1078Histone antibody positiveFAERS: 1US FAERS
1079HoloprosencephalyFAERS: 1US FAERS
1080HyperexplexiaFAERS: 1US FAERS
1081HyperkeratosisFAERS: 1US FAERS
1082HypermetabolismFAERS: 1US FAERS
1083HyperparathyroidismFAERS: 1US FAERS
1084HypertrichosisFAERS: 1US FAERS
1085Hypertrophic CardiomyopathyFAERS: 1US FAERS
1086HypertrophyFAERS: 1US FAERS
1087HypochondriasisFAERS: 1US FAERS
1088HypometabolismFAERS: 1US FAERS
1089Hypothermia neonatalFAERS: 1US FAERS
1090Hypotonic urinary bladderFAERS: 1US FAERS
1091Hypotonic-hyporesponsive episodeFAERS: 1US FAERS
1092Ideas of referenceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1093Idiopathic urticariaFAERS: 1US FAERS
1094Iliac artery occlusionFAERS: 1US FAERS
1095Immune thrombocytopenic purpuraFAERS: 1US FAERS
1096Implant site infectionFAERS: 1US FAERS
1097Inability to afford medicationFAERS: 1US FAERS
1098Inadequate lubricationFAERS: 1US FAERS
1099Incorrect drug administration durationFAERS: 1US FAERS
1100Incorrect route of drug administrationFAERS: 1US FAERS
1101Incorrect route of product administrationFAERS: 1US FAERS
1102Increased upper airway secretionFAERS: 1US FAERS
1103Infectious peritonitisFAERS: 1US FAERS
1104Inferiority complexFAERS: 1US FAERS
1105Infrequent bowel movementsFAERS: 1US FAERS
1106Insulin C-peptide increasedFAERS: 1US FAERS
1107Intentional dose omissionFAERS: 1US FAERS
1108Intercepted wrong patient selectedFAERS: 1US FAERS
1109Intermittent ClaudicationFAERS: 1US FAERS
1110Intervertebral Disc DegenerationFAERS: 1US FAERS
1111Intestinal PerforationFAERS: 1US FAERS
1112Intestinal infarctionFAERS: 1US FAERS
1113Intraocular pressure test abnormalFAERS: 1US FAERS
1114Intrauterine infectionFAERS: 1US FAERS
1115Irregular breathingFAERS: 1US FAERS
1116Jealous delusionFAERS: 1US FAERS
1117Keratoconjunctivitis SiccaFAERS: 1US FAERS
1118KetonuriaFAERS: 1US FAERS
1119Laboratory test interferenceFAERS: 1US FAERS
1120LabyrinthitisFAERS: 1US FAERS
1121Lack of spontaneous speechFAERS: 1US FAERS
1122Large intestine perforationFAERS: 1US FAERS
1123LaryngomalaciaFAERS: 1US FAERS
1124Left Ventricular HypertrophyFAERS: 1US FAERS
1125Left atrial dilatationFAERS: 1US FAERS
1126Left ventricular end-diastolic pressure increasedFAERS: 1US FAERS
1127Limb massFAERS: 1US FAERS
1128LipoatrophyFAERS: 1US FAERS
1129Liver AbscessFAERS: 1US FAERS
1130Locked-In SyndromeFAERS: 1US FAERS
1131LordosisFAERS: 1US FAERS
1132Low Cardiac Output SyndromeFAERS: 1US FAERS
1133Low birth weight babyFAERS: 1US FAERS
1134Low set earsFAERS: 1US FAERS
1135Lower respiratory tract infectionFAERS: 1US FAERS
1136Lupus-like syndromeFAERS: 1US FAERS
1137Lyme DiseaseFAERS: 1US FAERS
1138Lymphocyte percentage decreasedFAERS: 1US FAERS
1139LymphopeniaFAERS: 1US FAERS
1140Male sexual dysfunctionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1141MalocclusionFAERS: 1US FAERS
1142Manufacturing materials issueFAERS: 1US FAERS
1143MarasmusFAERS: 1US FAERS
1144MastocytosisFAERS: 1US FAERS
1145Mechanical ventilationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1146MeningoceleFAERS: 1US FAERS
1147MeningorrhagiaFAERS: 1US FAERS
1148MerycismFAERS: 1US FAERS
1149MetamorphopsiaFAERS: 1US FAERS
1150Metanephrine urine increasedFAERS: 1US FAERS
1151Metastases to stomachFAERS: 1US FAERS
1152Metastatic NeoplasmFAERS: 1US FAERS
1153MicrographiaFAERS: 1US FAERS
1154MicrophthalmosFAERS: 1US FAERS
1155MicrostomiaFAERS: 1US FAERS
1156Migraine with AuraFAERS: 1US FAERS
1157MiliariaFAERS: 1US FAERS
1158MoaningFAERS: 1US FAERS
1159Monocyte count increasedFAERS: 1US FAERS
1160Monocyte percentage increasedFAERS: 1US FAERS
1161MononeuritisFAERS: 1US FAERS
1162Mononeuropathy MultiplexFAERS: 1US FAERS
1163MoroseFAERS: 1US FAERS
1164Multiple Chemical SensitivityFAERS: 1US FAERS
1165Multiple drug overdoseFAERS: 1US FAERS
1166Multiple drug therapyFAERS: 1US FAERS
1167Muscle strainFAERS: 1US FAERS
1168Mycosis FungoidesFAERS: 1US FAERS
1169Myocarditis post infectionFAERS: 1US FAERS
1170MyocarditisFAERS: 1US FAERS
1171MyopathyFAERS: 1US FAERS
1172MyotoniaFAERS: 1US FAERS
1173Neonatal hepatomegalyFAERS: 1US FAERS
1174Neonatal multi-organ failureFAERS: 1US FAERS
1175Neonatal respiratory acidosisFAERS: 1US FAERS
1176Neonatal tachycardiaFAERS: 1US FAERS
1177Neonatal testicular torsionFAERS: 1US FAERS
1178Nerve BlockFAERS: 1US FAERS
1179Neurological examination abnormalFAERS: 1US FAERS
1180NeuropathyFAERS: 1US FAERS
1181Neurotransmitter level alteredFAERS: 1US FAERS
1182Neutrophil count decreasedFAERS: 1US FAERS
1183Nipple painFAERS: 1US FAERS
1184Occult blood positiveFAERS: 1US FAERS
1185OphthalmoplegiaFAERS: 1US FAERS
1186Oral pruritusFAERS: 1US FAERS
1187Oropharyngeal discomfortFAERS: 1US FAERS
1188OsteomyelitisFAERS: 1US FAERS
1189OsteopeniaFAERS: 1US FAERS
1190OsteosarcomaFAERS: 1US FAERS
1191Ovarian adenomaFAERS: 1US FAERS
1192Paranasal sinus discomfortFAERS: 1US FAERS
1193ParesisFAERS: 1US FAERS
1194Pelvic PainFAERS: 1US FAERS
1195PeriodontitisFAERS: 1US FAERS
1196PeritonitisFAERS: 1US FAERS
1197Perivascular dermatitisFAERS: 1US FAERS
1198Personality change due to a general medical conditionFAERS: 1US FAERS
1199Phantom painFAERS: 1US FAERS
1200PharyngitisFAERS: 1US FAERS
1201Pharyngolaryngeal PainFAERS: 1US FAERS
1202Phobia of drivingFAERS: 1US FAERS
1203Physical product label issueFAERS: 1US FAERS
1204Placental InsufficiencyFAERS: 1US FAERS
1205PlasmapheresisFAERS: 1US FAERS
1206Pleuritic painFAERS: 1US FAERS
1207Pneumatosis Cystoides IntestinalisFAERS: 1US FAERS
1208Pneumatosis intestinalisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1209Pneumococcal sepsisFAERS: 1US FAERS
1210PolychondritisFAERS: 1US FAERS
1211PolyuriaFAERS: 1US FAERS
1212PoriomaniaFAERS: 1US FAERS
1213Post-traumatic neck syndromeFAERS: 1US FAERS
1214Posterior reversible encephalopathy syndromeFAERS: 1US FAERS
1215Postoperative infectionFAERS: 1US FAERS
1216Pregnancy of partnerFAERS: 1US FAERS
1217Premature EjaculationFAERS: 1US FAERS
1218Premenstrual syndromeFAERS: 1US FAERS
1219Prescription drug used without a prescriptionFAERS: 1US FAERS
1220Procedural complicationFAERS: 1US FAERS
1221Procedural site reactionFAERS: 1US FAERS
1222Product compounding quality issueFAERS: 1US FAERS
1223Product contaminationFAERS: 1US FAERS
1224Product difficult to swallowFAERS: 1US FAERS
1225Product dispensing errorFAERS: 1US FAERS
1226Product expiration date issueFAERS: 1US FAERS
1227Product label issueFAERS: 1US FAERS
1228Product label on wrong productFAERS: 1US FAERS
1229Product origin unknownFAERS: 1US FAERS
1230Product package associated injuryFAERS: 1US FAERS
1231Product packaging confusionFAERS: 1US FAERS
1232Product use complaintFAERS: 1US FAERS
1233Productive CoughFAERS: 1US FAERS
1234ProstatismFAERS: 1US FAERS
1235Protein total decreasedFAERS: 1US FAERS
1236PrurigoFAERS: 1US FAERS
1237PseudarthrosisFAERS: 1US FAERS
1238Psychogenic seizureFAERS: 1US FAERS
1239Pulmonary artery stenosisFAERS: 1US FAERS
1240Pulmonary malformationFAERS: 1US FAERS
1241Pulmonary painFAERS: 1US FAERS
1242Pulmonary thrombosisFAERS: 1US FAERS
1243PurgingFAERS: 1US FAERS
1244PurulenceFAERS: 1US FAERS
1245PyelectasiaFAERS: 1US FAERS
1246PyelonephritisFAERS: 1US FAERS
1247PyodermaFAERS: 1US FAERS
1248QRS axis abnormalFAERS: 1US FAERS
1249QuadriplegiaFAERS: 1US FAERS
1250RadiculopathyFAERS: 1US FAERS
1251RegurgitationFAERS: 1US FAERS
1252Relapsing FeverFAERS: 1US FAERS
1253Renal tubular necrosisFAERS: 1US FAERS
1254Residual urineFAERS: 1US FAERS
1255Respiratory fume inhalation disorderFAERS: 1US FAERS
1256Retinal Artery OcclusionFAERS: 1US FAERS
1257Retinal depigmentationFAERS: 1US FAERS
1258Retinal exudatesFAERS: 1US FAERS
1259Rheumatic disorderFAERS: 1US FAERS
1260Rheumatoid factor increasedFAERS: 1US FAERS
1261Right atrial dilatationFAERS: 1US FAERS
1262Rocky Mountain Spotted FeverFAERS: 1US FAERS
1263Ruptured cerebral aneurysmFAERS: 1US FAERS
1264ScabFAERS: 1US FAERS
1265Schizoaffective DisorderFAERS: 1US FAERS
1266Schizoid Personality DisorderFAERS: 1US FAERS
1267Sciatic Nerve PalsyFAERS: 1US FAERS
1268Seizure like phenomenaFAERS: 1US FAERS
1269Selenium deficiencyFAERS: 1US FAERS
1270Self-induced vomitingFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1271Senile dementiaFAERS: 1US FAERS
1272Sensory integrative dysfunctionFAERS: 1US FAERS
1273Septic ShockFAERS: 1US FAERS
1274Sexual activity increasedFAERS: 1US FAERS
1275Shoulder DystociaFAERS: 1US FAERS
1276Shoulder PainFAERS: 1US FAERS
1277Similar reaction on previous exposure to drugFAERS: 1US FAERS
1278Skin hypoplasiaFAERS: 1US FAERS
1279Skin reactionFAERS: 1US FAERS
1280Sleep-related eating disorderFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1281Sperm concentration decreasedFAERS: 1US FAERS
1282Sperm count decreasedFAERS: 1US FAERS
1283Spermatozoa morphology abnormalFAERS: 1US FAERS
1284Spermatozoa progressive motility decreasedFAERS: 1US FAERS
1285Spina BifidaFAERS: 1US FAERS
1286Spinal column injuryFAERS: 1US FAERS
1287SplinterFAERS: 1US FAERS
1288SpondylitisFAERS: 1US FAERS
1289StaringFAERS: 1US FAERS
1290Stenotrophomonas infectionFAERS: 1US FAERS
1291Stoma obstructionFAERS: 1US FAERS
1292StubbornnessFAERS: 1US FAERS
1293SubileusFAERS: 1US FAERS
1294Sudden onset of sleepFAERS: 1US FAERS
1295SunburnFAERS: 1US FAERS
1296Superinfection lungFAERS: 1US FAERS
1297Surgical failureFAERS: 1US FAERS
1298SyndactylyFAERS: 1US FAERS
1299Systemic Inflammatory Response SyndromeFAERS: 1US FAERS
1300Teeth brittleFAERS: 1US FAERS
1301Therapeutic product effect decreasedFAERS: 1
Canada Vigilance: 13
Canada Vigilance
US FAERS
1302Therapeutic product ineffectiveFAERS: 1US FAERS
1303Therapeutic response delayedFAERS: 1US FAERS
1304Therapy regimen changedFAERS: 1US FAERS
1305Thoracic Outlet SyndromeFAERS: 1US FAERS
1306Thoracic vertebral fractureFAERS: 1US FAERS
1307Thought withdrawalFAERS: 1US FAERS
1308Throat cancerFAERS: 1US FAERS
1309Thromboangiitis ObliteransFAERS: 1US FAERS
1310Thyroid NeoplasmFAERS: 1US FAERS
1311ThyroiditisFAERS: 1US FAERS
1312Tongue exfoliationFAERS: 1US FAERS
1313Tonic clonic movementsFAERS: 1US FAERS
1314TonsillitisFAERS: 1US FAERS
1315Tooth InfectionFAERS: 1US FAERS
1316TorticollisFAERS: 1US FAERS
1317TracheomalaciaFAERS: 1US FAERS
1318Transfusion-Related Acute Lung InjuryFAERS: 1US FAERS
1319TransplantFAERS: 1US FAERS
1320Trigeminal NeuralgiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1321Troponin I increasedFAERS: 1US FAERS
1322TruancyFAERS: 1US FAERS
1323Ulnar Nerve PalsyFAERS: 1US FAERS
1324Urethritis noninfectiveFAERS: 1US FAERS
1325Urine flow decreasedFAERS: 1US FAERS
1326Uterine CancerFAERS: 1US FAERS
1327Uterine PolypFAERS: 1US FAERS
1328Uterine contractions during pregnancyFAERS: 1US FAERS
1329VIth nerve paresisFAERS: 1US FAERS
1330Vascular resistance systemic decreasedFAERS: 1US FAERS
1331Vascular ruptureFAERS: 1US FAERS
1332Venous ThrombosisFAERS: 1US FAERS
1333Venous occlusionFAERS: 1US FAERS
1334Ventricular DysfunctionFAERS: 1US FAERS
1335Ventricular enlargementFAERS: 1US FAERS
1336Ventricular internal diameter abnormalFAERS: 1US FAERS
1337Violent ideationFAERS: 1US FAERS
1338Viral myocarditisFAERS: 1US FAERS
1339Viral pericarditisFAERS: 1US FAERS
1340Vitamin D DeficiencyFAERS: 1US FAERS
1341Vitamin E DeficiencyFAERS: 1US FAERS
1342VitrectomyFAERS: 1US FAERS
1343Vitreous DetachmentFAERS: 1US FAERS
1344Vulvovaginal pruritusFAERS: 1US FAERS
1345Water IntoxicationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1346White blood cell count abnormalFAERS: 1US FAERS
1347Withdrawal arrhythmiaFAERS: 1US FAERS
1348Wound InfectionFAERS: 1US FAERS
1349Wound decompositionFAERS: 1US FAERS
1350Zinc deficiencyFAERS: 1US FAERS
1351colonoscopyFAERS: 1US FAERS
1352kyphosisFAERS: 1US FAERS
1353pH urine increasedFAERS: 1US FAERS
1354skin abrasionFAERS: 1US FAERS
1355Allergic sinusitisCanada Vigilance: 1Canada Vigilance
1356Amenorrhea19303910CTD
1357Anxiety Disorders17284507CTD
1358Basal Ganglia Diseases10435776CTD
1359Chemical and Drug Induced Liver Injury10375350
10691596
15930079
CTD
1360Cocaine-Related Disorders10718161CTD
1361Confusion8888541
11816261
CTD
1362Depressive disorder

View details

CTD
1363Disorders of Excessive Somnolence15699296CTD
1364Disruptive, Impulse Control, and Conduct Disorders12680750CTD
1365Drug Overdose9034419
19131198
CTD
1366Dysthymic Disorder17606668CTD
1367Excessive eye blinkingCanada Vigilance: 1Canada Vigilance
1368Facial paralysisCanada Vigilance: 2Canada Vigilance
1369Female Orgasmic DisorderCanada Vigilance: 1Canada Vigilance
1370Fever8700462
8888541
11816261
CTD
1371Galactorrhea-Hyperprolactinemia17606668CTD
1372Galactorrhea19303910CTD
1373Hallucinations18303146CTD
1374Heart failure12663337CTD
1375Hyperalgesia12865165CTD
1376HyperkinesiaCanada Vigilance: 1Canada Vigilance
1377Hyperprolactinemia19303910CTD
1378HypogeusiaCanada Vigilance: 1Canada Vigilance
1379Hyponatremia17189754CTD
1380Illogical thinkingCanada Vigilance: 1Canada Vigilance
1381Intestinal FistulaCanada Vigilance: 1Canada Vigilance
1382Intestinal transit time abnormalCanada Vigilance: 1Canada Vigilance
1383Lactose IntoleranceCanada Vigilance: 1Canada Vigilance
1384Liver Failure, Acute19857765CTD
1385LymphomaCanada Vigilance: 1Canada Vigilance
1386Mental disorders16856516CTD
1387Migraine Disorders9674820
18803445
CTD
1388Mood Disorders15610935CTD
1389Motor Disorders25423262CTD
1390Movement Disorders11816261CTD
1391Neonatal respiratory distressCanada Vigilance: 5Canada Vigilance
1392Nephritis, Interstitial10513719CTD
1393Neurobehavioral Manifestations10367559CTD
1394Neurotoxicity Syndromes12187335CTD
1395OliguriaCanada Vigilance: 1Canada Vigilance
1396Oral mucosal eruptionCanada Vigilance: 1Canada Vigilance
1397Paresthesia12187335CTD
1398Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
1399Product administration errorCanada Vigilance: 1Canada Vigilance
1400Product complaintCanada Vigilance: 1Canada Vigilance
1401Product tamperingCanada Vigilance: 1Canada Vigilance
1402Psychomotor Agitation18303146CTD
1403Psychoses, Substance-Induced11949740CTD
1404Seizures

View details

CTD
1405Sialorrhea8888541CTD
1406Sleep Bruxism11157444CTD
1407Sleep Initiation and Maintenance Disorders15699296CTD
1408Substance Withdrawal Syndrome

View details

CTD
1409Tobacco Use Disorder16366758CTD
1410Vasculitic rashCanada Vigilance: 1Canada Vigilance
1411Xerostomia15699296
17606668
CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.